NEWS + PRESS

Policy growth reflects strong execution and expanding distribution across RELI Exchange platform

Broker network expanded from approximately 65 to approximately 300 since acquisition in 2022

LAKEWOOD, NJ, Jan. 30, 2026 (GLOBE NEWSWIRE) — Reliance Global Group, Inc. (Nasdaq: EZRA) (the “Company”) today announced strong operating momentum across its insurance operations, highlighted by a significant year-over-year increase in health insurance policies written through its RELI Exchange, LLC subsidiary during the 2025 open enrollment period.

During the 2025 open enrollment period, health insurance policies written through RELI Exchange’s Altruis Health office increased to approximately 3,873 policies, compared to approximately 2,258 policies during the 2024 open enrollment period, representing an increase of approximately 72% year over year. The Company believes this growth reflects improved execution, deeper carrier relationships, and the continued scaling of its insurance distribution platform.

The increase in policy production further demonstrates the scalability of RELI Exchange as the business continues to expand its distribution footprint. Since acquiring RELI Exchange in 2022, Reliance has grown its broker network from approximately 65 agency partners to approximately 300 agency partners, with growth driven organically, significantly increasing reach while supporting higher volumes of policy production across its platform.

The strength and cash-generating nature of RELI Exchange also supports the Company’s broader strategic initiatives through EZRA International Group (“EZRA”), which was established to pursue controlling investments in high-growth, technology-driven businesses. Since launching EZRA, the Company has announced its first planned acquisition of a controlling interest in a company developing non-invasive, breath-based diagnostic technologies, as well as a subsequent term sheet to acquire a controlling interest in a post-quantum cybersecurity technology company. These initiatives reflect a disciplined approach to building a portfolio of transformative technology assets supported by the Company’s insurance operations.

“Insurance is the foundation of this Company, and the results we are seeing at RELI Exchange demonstrate the scalability of our platform,” said Ezra Beyman, Chairman and Chief Executive Officer of Reliance Global Group. “A 72% increase in health insurance policies written during the most recent open enrollment period reflects our ability to expand distribution, deepen carrier relationships, and execute effectively, driven by organic growth at RELI Exchange. This operating momentum strengthens the foundation of our insurance business and supports our continued efforts to build EZRA as a long-term growth engine.”

About Reliance Global Group, Inc.

Reliance Global Group, Inc. (NASDAQ: EZRA) is an InsurTech pioneer, leveraging artificial intelligence (AI), and cloud-based technologies, to transform and improve efficiencies in the insurance agency/brokerage industry. The Company’s business-to-business InsurTech platform, RELI Exchange, provides independent insurance agencies an entire suite of business development tools, enabling them to effectively compete with large-scale national insurance agencies, whilst reducing back-office cost and burden. The Company’s business-to-consumer platform, 5minuteinsure.com, utilizes AI and data mining, to provide competitive online insurance quotes within minutes to everyday consumers seeking to purchase auto, home, and life insurance. In addition, the Company operates its own portfolio of select retail “brick and mortar” insurance agencies which are leaders and pioneers in their respective regions throughout the United States, offering a wide variety of insurance products.

In addition to its insurance and insurtech operations, Reliance operates EZRA International Group, its strategic growth platform focused on identifying, acquiring, and building majority or controlling stakes in high-growth technology companies. EZRA International Group is designed to complement Reliance’s core insurance business by expanding market reach and supporting long-term shareholder value creation through disciplined capital allocation and active ownership.

Further information about the Company can be found at https://www.relianceglobalgroup.com.

Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. You can identify these statements by terminology such as “may,” “should,” “could,” “would,” “will,” “expect,” “anticipate,” “intend,” “plan,” “believe,” “estimate,” “continue,” “potential,” and similar expressions. Forward-looking statements in this press release include, without limitation, statements regarding the Company’s strategic initiatives, including the role of EZRA International Group in identifying, structuring and pursuing acquisition and investment opportunities; the anticipated benefits of the expanded responsibilities of senior management, including the promotion of Moshe Fishman to Senior Vice President, Strategic Ventures; the Company’s ability to execute its acquisition and investment strategy through EZRA International Group; the growth prospects and scalability of RELI Exchange and 5minuteinsure.com; and the Company’s broader business, strategic and financial outlook.

These forward-looking statements are based on current expectations and assumptions that involve risks and uncertainties, including, among others, that the Company will be able to successfully execute its strategic initiatives and acquisition strategy through EZRA International Group; that the expanded leadership role of senior management will contribute to the effective sourcing, structuring and integration of strategic opportunities; that investments in RELI Exchange, 5minuteinsure.com and other initiatives will generate anticipated returns; that market, economic, interest rate and regulatory conditions will remain sufficiently favorable; and that the Company will be able to continue to access capital on acceptable terms and execute its broader business and capital markets strategy. There can be no assurance that these assumptions will prove accurate.

Actual results could differ materially from those anticipated due to a variety of risks and uncertainties, including, without limitation: the Company’s ability to successfully identify, evaluate, consummate and integrate acquisitions or strategic investments through EZRA International Group; the risk that anticipated benefits of management changes or strategic initiatives may not be realized; the Company’s ability to grow RELI Exchange and 5minuteinsure.com, attract and retain agents and customers, and achieve expected levels of adoption and profitability; the Company’s ability to effectively deploy capital into business development or other strategic initiatives; the Company’s ability to maintain adequate liquidity and access to capital (including any issuance under its at-the-market equity offering program, if utilized); competitive pressures, including within InsurTech and insurance agency/brokerage; and general business, economic, market, interest rate and geopolitical conditions; as well as other risks described under “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024, as amended, the Company’s Quarterly Reports on Form 10-Q, and in other filings with the Securities and Exchange Commission.

Except as required by law, Reliance Global Group, Inc. undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.

Contact:

Crescendo Communications, LLC
Tel: +1 (212) 671-1020
Email: EZRA@crescendo-ir.com

LAKEWOOD, N.J., Jan. 29, 2026 (GLOBE NEWSWIRE) — Reliance Global Group, Inc. (Nasdaq: EZRA) (the “Company”) today announced the closing of its previously announced public offering of 7,407,408 shares of common stock (or pre-funded warrants in lieu thereof), together with warrants to purchase up to 14,814,816 shares of common stock at a combined public offering price of $0.27 per share (or pre-funded warrant in lieu thereof) and associated warrants. The warrants have an exercise price of $0.27 per share, are exercisable upon issuance and will expire two years thereafter.

H.C. Wainwright & Co. acted as the exclusive placement agent for the offering.

The gross proceeds to the Company from the offering were approximately $2 million, before deducting the placement agent’s fees and other offering expenses payable by the Company. The Company intends to use the net proceeds from this offering for working capital, its M&A strategies and general corporate purposes.

A registration statement on Form S-1 (File No. 333-292895) relating to the offering was declared effective by the Securities and Exchange Commission (the “SEC”) on January 28, 2026. The offering was made only by means of a prospectus forming part of the effective registration statement relating to the offering. A final prospectus relating to the offering has been filed with the SEC. Electronic copies of the final prospectus may be obtained on the SEC’s website at http://www.sec.gov and may also be obtained by contacting H.C. Wainwright & Co., LLC at 430 Park Avenue, 3rd Floor, New York, NY 10022, by phone at (212) 856-5711 or e-mail at placements@hcwco.com.

This press release does not constitute an offer to sell or the solicitation of an offer to buy any of the securities described herein, nor shall there be any sale of these securities in any state or other jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or other jurisdiction.

About Reliance Global Group, Inc.

Reliance Global Group, Inc. (NASDAQ: EZRA) is an InsurTech pioneer, leveraging artificial intelligence (AI), and cloud-based technologies, to transform and improve efficiencies in the insurance agency/brokerage industry. The Company’s business-to-business InsurTech platform, RELI Exchange, provides independent insurance agencies an entire suite of business development tools, enabling them to effectively compete with large-scale national insurance agencies, whilst reducing back-office cost and burden. The Company’s business-to-consumer platform, 5minuteinsure.com, utilizes AI and data mining, to provide competitive online insurance quotes within minutes to everyday consumers seeking to purchase auto, home, and life insurance. In addition, the Company operates its own portfolio of select retail “brick and mortar” insurance agencies which are leaders and pioneers in their respective regions throughout the United States, offering a wide variety of insurance products. Further information about the Company can be found at https://www.relianceglobalgroup.com.

Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. You can identify forward-looking statements by terminology such as “may,” “should,” “could,” “would,” “will,” “expect,” “anticipate,” “intend,” “plan,” “believe,” “estimate,” “continue,” “potential,” “designed to,” “aim,” “seek,” and similar expressions. Forward-looking statements in this press release include, without limitation, statements regarding the intended use of net proceeds from the offering. These forward-looking statements are based on current expectations and assumptions that involve risks and uncertainties. There can be no assurance that these assumptions will prove accurate. Actual results could differ materially from those anticipated due to a variety of risks and uncertainties, including, without limitation, the risks described under “Risk Factors” in our registration statement on Form S-1 (File No. 333-292895) filed with the Securities and Exchange Commission. You are encouraged to carefully review such registration statement for a more complete discussion of these and other risks and uncertainties. Except as required by law, Reliance Global Group, Inc. undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Contact:

Crescendo Communications, LLC
Tel: +1 (212) 671-1020
Email: EZRA@crescendo-ir.com

LAKEWOOD, NJ, Jan. 28, 2026 — Reliance Global Group, Inc. (Nasdaq: EZRA) (the “Company”) today announced the pricing of a public offering of 7,407,408 shares of common stock (or pre-funded warrants in lieu thereof), together with warrants to purchase up to 14,814,816 shares of common stock at a combined public offering price of $0.27 per share (or pre-funded warrant in lieu thereof) and associated warrants. The warrants will have an exercise price of $0.27 per share, will be exercisable upon issuance and will expire two years thereafter. The closing of the offering is expected to occur on or about January 29, 2026, subject to the satisfaction of customary closing conditions.

H.C. Wainwright & Co. is acting as the exclusive placement agent for the offering.

The gross proceeds to the Company from the offering are expected to be approximately $2 million, before deducting the placement agent’s fees and other offering expenses payable by the Company. The Company intends to use the net proceeds from this offering for working capital, its M&A strategies and general corporate purposes.

A registration statement on Form S-1 (File No. 333-292895) relating to the offering was declared effective by the Securities and Exchange Commission (the “SEC”) on January 28, 2026. The offering is being made only by means of a prospectus forming part of the effective registration statement relating to the offering. A preliminary prospectus relating to the offering has been filed with the SEC. Electronic copies of the final prospectus, when available, may be obtained on the SEC’s website at http://www.sec.gov and may also be obtained, when available, by contacting H.C. Wainwright & Co., LLC at 430 Park Avenue, 3rd Floor, New York, NY 10022, by phone at (212) 856-5711 or e-mail at placements@hcwco.com.

This press release does not constitute an offer to sell or the solicitation of an offer to buy any of the securities described herein, nor shall there be any sale of these securities in any state or other jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or other jurisdiction.

About Reliance Global Group, Inc.

Reliance Global Group, Inc. (NASDAQ: EZRA) is an InsurTech pioneer, leveraging artificial intelligence (AI), and cloud-based technologies, to transform and improve efficiencies in the insurance agency/brokerage industry. The Company’s business-to-business InsurTech platform, RELI Exchange, provides independent insurance agencies an entire suite of business development tools, enabling them to effectively compete with large-scale national insurance agencies, whilst reducing back-office cost and burden. The Company’s business-to-consumer platform, 5minuteinsure.com, utilizes AI and data mining, to provide competitive online insurance quotes within minutes to everyday consumers seeking to purchase auto, home, and life insurance. In addition, the Company operates its own portfolio of select retail “brick and mortar” insurance agencies which are leaders and pioneers in their respective regions throughout the United States, offering a wide variety of insurance products. Further information about the Company can be found at https://www.relianceglobalgroup.com.

Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. You can identify forward-looking statements by terminology such as “may,” “should,” “could,” “would,” “will,” “expect,” “anticipate,” “intend,” “plan,” “believe,” “estimate,” “continue,” “potential,” “designed to,” “aim,” “seek,” and similar expressions. Forward-looking statements in this press release include, without limitation, statements regarding: the completion of the offering, the satisfaction of customary closing conditions related to the offering and the intended use of net proceeds from the offering. These forward-looking statements are based on current expectations and assumptions that involve risks and uncertainties. There can be no assurance that these assumptions will prove accurate. Actual results could differ materially from those anticipated due to a variety of risks and uncertainties, including, without limitation, the risks described under “Risk Factors” in our registration statement on Form S-1 (File No. 333-292895) filed with the Securities and Exchange Commission. You are encouraged to carefully review such registration statement for a more complete discussion of these and other risks and uncertainties. Except as required by law, Reliance Global Group, Inc. undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Contact:

Crescendo Communications, LLC
Tel: +1 (212) 671-1020
Email: EZRA@crescendo-ir.com

LAKEWOOD, N.J., Jan. 28, 2026 — Reliance Global Group, Inc. (Nasdaq: EZRA) (the “Company”) today announced the promotion of Moshe Fishman to Senior Vice President, Strategic Ventures.

In this expanded role, Mr. Fishman will continue to drive the growth of Reliance’s core insurance and insurtech operations while leading the Company’s efforts to identify and execute opportunities through EZRA Group International (“EZRA”), Reliance’s strategic acquisition initiative.

Reliance’s insurance business remains the foundation of the Company, generating revenue and cash flow through agency distribution, carrier relationships, and technology-enabled processes. Since joining Reliance in 2021, Mr. Fishman has been a driving force in incorporating technology and artificial intelligence into the Company’s insurance operations, helping modernize workflows, improve data utilization, and support scalable growth through greater operating efficiency.

EZRA was formed to pursue majority or controlling stakes in what we believe to be high-growth technology companies operating outside traditional insurance, where Reliance seeks to act as a long-term owner and value builder. The initiative is focused on opportunities that we believe have the potential to materially expand Reliance’s growth profile over time through exposure to transformative technologies, supported by a disciplined transaction approach and active post-close execution.

In his new role, Mr. Fishman will lead the execution and scaling of the EZRA platform, including sourcing and evaluating opportunities, structuring and leading transactions, and working closely with acquired companies after closing, while continuing to support day-to-day operations of the Company’s core insurance business. He has been deeply involved throughout the transaction process on current initiatives, working hands-on with counterparties to advance acquisitions from initial structuring through closing and integration.

Mr. Fishman has been closely involved in Reliance’s recently announced majority stake acquisition in Scentech Medical, an AI-driven diagnostics company focused on early disease detection, and Enquantum Ltd., a cybersecurity company developing post-quantum encryption and next-generation data protection technologies. The Company believes that these transactions reflect EZRA’s focus on transformative technologies with significant long-term potential.

“Moshe has been directly involved in strengthening our insurance operations through technology while also helping launch and advance our EZRA strategy,” said Ezra Beyman, Chairman and Chief Executive Officer of Reliance. “From early transaction structuring through quarterbacking the definitive agreement process, Moshe is already demonstrating strong leadership, working closely with principals and legal counsel to drive transactions toward closing and integration. He is actively engaging with a wide range of high-quality companies and continuously evaluating opportunities that have the potential to unlock meaningful long-term value for our shareholders. We believe Moshe’s experience and execution mindset are critical as we move from strategy formation to platform execution and build EZRA into a scalable engine for long-term value creation alongside our growing retail insurance business.”

“Our insurance business provides a stable and growing foundation for the Company,” said Moshe Fishman. “EZRA allows us to pursue long-term growth opportunities. My focus is disciplined execution in insurance and thoughtful, selective acquisitions through EZRA as the Company continues to evolve.”

About Reliance Global Group, Inc.

Reliance Global Group, Inc. (NASDAQ: EZRA) is an InsurTech pioneer, leveraging artificial intelligence (AI), and cloud-based technologies, to transform and improve efficiencies in the insurance agency/brokerage industry. The Company’s business-to-business InsurTech platform, RELI Exchange, provides independent insurance agencies an entire suite of business development tools, enabling them to effectively compete with large-scale national insurance agencies, whilst reducing back-office cost and burden. The Company’s business-to-consumer platform, 5minuteinsure.com, utilizes AI and data mining, to provide competitive online insurance quotes within minutes to everyday consumers seeking to purchase auto, home, and life insurance. In addition, the Company operates its own portfolio of select retail “brick and mortar” insurance agencies which are leaders and pioneers in their respective regions throughout the United States, offering a wide variety of insurance products.

In addition to its insurance and insurtech operations, Reliance operates EZRA International Group, its strategic growth platform focused on identifying, acquiring, and building majority or controlling stakes in high-growth technology companies. EZRA International Group is designed to complement Reliance’s core insurance business by expanding market reach and supporting long-term shareholder value creation through disciplined capital allocation and active ownership.

Further information about the Company can be found at https://www.relianceglobalgroup.com.

Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. You can identify these statements by terminology such as “may,” “should,” “could,” “would,” “will,” “expect,” “anticipate,” “intend,” “plan,” “believe,” “estimate,” “continue,” “potential,” and similar expressions. Forward-looking statements in this press release include, without limitation, statements regarding the Company’s strategic initiatives, including the role of EZRA International Group in identifying, structuring and pursuing acquisition and investment opportunities; the anticipated benefits of the expanded responsibilities of senior management, including the promotion of Moshe Fishman to Senior Vice President, Strategic Ventures; the Company’s ability to execute its acquisition and investment strategy through EZRA International Group; the growth prospects and scalability of RELI Exchange and 5minuteinsure.com; and the Company’s broader business, strategic and financial outlook.

These forward-looking statements are based on current expectations and assumptions that involve risks and uncertainties, including, among others, that the Company will be able to successfully execute its strategic initiatives and acquisition strategy through EZRA International Group; that the expanded leadership role of senior management will contribute to the effective sourcing, structuring and integration of strategic opportunities; that investments in RELI Exchange, 5minuteinsure.com and other initiatives will generate anticipated returns; that market, economic, interest rate and regulatory conditions will remain sufficiently favorable; and that the Company will be able to continue to access capital on acceptable terms and execute its broader business and capital markets strategy. There can be no assurance that these assumptions will prove accurate.

Actual results could differ materially from those anticipated due to a variety of risks and uncertainties, including, without limitation: the Company’s ability to successfully identify, evaluate, consummate and integrate acquisitions or strategic investments through EZRA International Group; the risk that anticipated benefits of management changes or strategic initiatives may not be realized; the Company’s ability to grow RELI Exchange and 5minuteinsure.com, attract and retain agents and customers, and achieve expected levels of adoption and profitability; the Company’s ability to effectively deploy capital into business development or other strategic initiatives; the Company’s ability to maintain adequate liquidity and access to capital (including any issuance under its at-the-market equity offering program, if utilized); competitive pressures, including within InsurTech and insurance agency/brokerage; and general business, economic, market, interest rate and geopolitical conditions; as well as other risks described under “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024, as amended, the Company’s Quarterly Reports on Form 10-Q, and in other filings with the Securities and Exchange Commission.

Except as required by law, Reliance Global Group, Inc. undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.

Contact:

Crescendo Communications, LLC
Tel: +1 (212) 671-1020
Email: EZRA@crescendo-ir.com

LAKEWOOD, NJ, Jan. 26, 2026 — Reliance Global Group, Inc. (Nasdaq: EZRA) (the “Company”) today announced that it has entered into a non-binding term sheet to acquire a controlling interest in Enquantum Ltd., a post-quantum cryptography technology company addressing what many experts view as an emerging and systemic threat to essential global services and digital infrastructure that rely on encryption for security. In addition, in connection with the term sheet, On January 15, 2026, Reliance executed a secured promissory note as an advance of the initial funding under a definitive agreement, if executed. The Promissory Note is secured by all of the assets of Enquantum and payable within 60 days of its issuance date if a definitive agreement is not entered into. If a definitive agreement is entered into, the balance due under the Promissory Note will be applied against the first two payment milestones.

Under the terms of the term sheet, Reliance, through its recently established subsidiary, EZRA International Group, a newly formed division focused on acquiring controlling stakes of high-tech companies, intends to pursue a controlling ownership position in Enquantum through a structured, milestone-based investment process over the next twelve months, subject to the negotiation and execution of definitive agreements, completion of due diligence, and customary closing conditions.

As quantum computing continues to advance, cybersecurity experts increasingly warn that existing cryptographic standards may become obsolete, fundamentally affecting the security of critical global infrastructure. This shift is accelerating as industry progress brings quantum computing closer to levels capable of challenging the encryption systems that underpin today’s financial networks, cloud infrastructure, artificial intelligence workloads, telecommunications networks, and government communications, driving growing urgency across governments, enterprises, and hyperscale operators to transition toward post-quantum cryptography (PQC)-security frameworks designed to remain resilient in a quantum-enabled environment. Industry experts increasingly view this transition not as optional, but as an eventual, mandatory upgrade across critical digital infrastructure.

Enquantum was founded specifically to address this challenge. The company intends to implement NIST-compliant post-quantum cryptographic hardware cores that delivery speed, power, efficiency and security as compared to software-only approaches. Post-quantum cryptography algorithms and implementations can introduce performance trade-offs – including increased computational cost, execution time, and resource overheads compared with legacy cryptographic schemes – particularly in software-only deployments, as noted in recent performance studies. By contrast, Enquantum’s approach is being designed with the objective of supporting terabit-level Ethernet speeds, potentially allowing organizations to transition to post-quantum security without compromising operations. In 2025, Enquantum was granted a patent relating to methods and systems for FPGA-based encrypted communications, including hash-based encryption techniques described in the patent as quantum-resistant.

Ezra Beyman, Chairman and Chief Executive Officer of Reliance Global Group, stated, “Quantum computing represents a rare inflection point where technological progress directly undermines the security assumptions of the modern digital economy. When that line is crossed, existing encryption standards don’t weaken gradually-they break. Enquantum is building a solution designed for that moment: quantum-resilient, performance-driven, and deployable at enterprise scale, aligned with EZRA International Group’s focus.”

Moshe Fishman, Director of Operations, added, “We believe that post-quantum cryptography will be one of the largest forced technology transitions in the cybersecurity industry. The market for PQC is rapidly increasing and is expected to reach $2.84 Billion by 2030 as new cyber regulation begins to take effect. In order to adequately protect data from the quantum computing risk exposure, PQC has to be in place long before the current cyber security infrastructure is challenged by the impending introduction of quantum computing. Even before current encryption standards begin to fail, organizations won’t debate whether to upgrade, they will have no alternative. The early capital advance reflects our confidence while maintaining appropriate structural protections.”

Fishman continued, “What makes Enquantum compelling is that it is developing a solution that doesn’t just identify the problem, we believe it addresses it in a way the market can adopt. We believe that hardware-accelerated, quantum-resilient security at scale is exactly what data centers, financial institutions, AI infrastructure providers, and government networks will need. EZRA International Group was formed to capture potential value from these kinds of structural shifts.”

Reliance believes the market opportunity for post-quantum security spans hyperscale and AI-driven data centers, financial services, telecommunications, government and defense networks, and long-lifecycle critical infrastructure-markets where performance, compliance, and resilience are non-negotiable and where hardware-accelerated solutions can offer a decisive advantage.

The term sheet is non-binding and conditional on executing definitive agreements and completing a thorough diligence review, which is well under way. There can be no assurance that a definitive agreement will be executed, that the proposed transaction will be completed on favorable terms or at all. Reliance will provide additional updates as appropriate and in accordance with applicable disclosure requirements.

About Reliance Global Group, Inc.

Reliance Global Group, Inc. (NASDAQ: EZRA) is an InsurTech pioneer, leveraging artificial intelligence (AI), and cloud-based technologies, to transform and improve efficiencies in the insurance agency/brokerage industry. The Company’s business-to-business InsurTech platform, RELI Exchange, provides independent insurance agencies an entire suite of business development tools, enabling them to effectively compete with large-scale national insurance agencies, whilst reducing back-office cost and burden. The Company’s business-to-consumer platform, 5minuteinsure.com, utilizes AI and data mining, to provide competitive online insurance quotes within minutes to everyday consumers seeking to purchase auto, home, and life insurance. In addition, the Company operates its own portfolio of select retail “brick and mortar” insurance agencies which are leaders and pioneers in their respective regions throughout the United States, offering a wide variety of insurance products. Further information about the Company can be found at https://www.relianceglobalgroup.com.

Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. You can identify forward-looking statements by terminology such as “may,” “should,” “could,” “would,” “will,” “expect,” “anticipate,” “intend,” “plan,” “believe,” “estimate,” “continue,” “potential,” “designed to,” “aim,” “seek,” and similar expressions.

Forward-looking statements in this press release include, without limitation, statements regarding: our proposed acquisition of a controlling interest in Enquantum Ltd. pursuant to a non-binding term sheet, including the anticipated timing, structure, milestone-based funding mechanics and other potential terms of any such transaction; our ability to complete due diligence, negotiate and execute definitive agreements, satisfy closing conditions and obtain any required approvals in connection with any potential transaction; the terms, enforceability, repayment and application of the secured promissory note executed in connection with the term sheet, including whether and how any amounts advanced may be applied against milestone payments under a definitive agreement, if executed; the anticipated strategic rationale for, and potential benefits of, any potential transaction involving Enquantum (including through EZRA International Group); the development, performance, scalability, commercialization and market adoption of Enquantum’s technology; statements regarding the intended design and implementation of NIST-compliant post-quantum cryptographic hardware cores and related performance objectives (including speed, power efficiency and security characteristics); the size, growth and evolution of the post-quantum cybersecurity market (including any market forecasts); and our broader business, strategic and financial outlook, including our ability to fund and execute our acquisition and growth strategy and access capital on acceptable terms (including under our at-the-market equity offering program, if utilized).

These forward-looking statements are based on current expectations and assumptions that involve risks and uncertainties, including, among others, that our due diligence of Enquantum can be completed on a timeline acceptable to us (or at all) and will not identify issues that cause us to renegotiate or abandon the proposed transaction; that definitive agreements can be negotiated and executed on acceptable terms; that any required corporate, stockholder, regulatory or third-party approvals (if any) can be obtained; that any closing conditions can be satisfied; that the parties will perform their obligations under the secured promissory note in accordance with its terms, including repayment and/or application of amounts advanced as contemplated; that Enquantum’s technology can be developed and implemented as expected and achieve anticipated performance and market adoption; that any intended NIST-aligned implementation can be achieved on the anticipated timeline (or at all) and will satisfy applicable standards and customer requirements; that cryptographic standards, customer requirements and regulatory frameworks will evolve as anticipated; and that we will be able to fund any potential transaction and related initiatives through existing resources and/or access to capital on acceptable terms. There can be no assurance that these assumptions will prove accurate.

Actual results could differ materially from those anticipated due to a variety of risks and uncertainties, including, without limitation: the risk that the term sheet with Enquantum is non-binding and may be terminated or may not result in a definitive agreement; the risk that we do not complete due diligence, or that due diligence identifies risks or liabilities (including with respect to intellectual property, regulatory compliance, cybersecurity, financial condition, litigation or technical feasibility) that cause us to abandon or materially change the contemplated transaction; the risk that required approvals or consents are delayed, not obtained or impose conditions that adversely affect us; the risk that amounts advanced under the secured promissory note are not repaid when due or are not applied as contemplated, and that enforcement, collection or realization on collateral (if any) may be delayed, limited or unsuccessful; the risk that Enquantum’s technology does not perform as expected or is not adopted by the market; rapid changes in technology, cryptographic standards and competitive dynamics; the risk that third-party market estimates or forecasts regarding the size or growth of the post-quantum cybersecurity market prove inaccurate; our ability to maintain adequate liquidity and access to capital; competitive pressures; and general business, economic, market, interest rate and geopolitical conditions, as well as other risks described under “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2024, as amended, our Quarterly Reports on Form 10-Q, and in other filings with the Securities and Exchange Commission.

You are encouraged to carefully review our filings with the Securities and Exchange Commission for a more complete discussion of these and other risks and uncertainties. Except as required by law, Reliance Global Group, Inc. undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Contact:

Crescendo Communications, LLC
Tel: +1 (212) 671-1020
Email: EZRA@crescendo-ir.com

Company to Begin Trading Under New Symbol “EZRA” on January 26, 2026

Acquisition Strategy Offers Transformative Potential,
Complementing Cash Flow Foundation of Insurance Holdings

LAKEWOOD, NJ, Jan. 22, 2026 — Reliance Global Group, Inc. (Nasdaq: RELI) (the “Company”) today announced that its ticker symbol on the NASDAQ Capital Market will change from “RELI” to “EZRA”, effective at the open of trading on Monday, January 26, 2026. The Company’s common stock will continue to be listed on NASDAQ, and its CUSIP number will remain unchanged.

The ticker symbol change is intended to better reflect the Company’s strategic evolution, including the formation of EZRA International Group, a new division focused on acquiring controlling stakes and accelerating the growth of breakthrough technology companies, with an initial emphasis on businesses operating across sectors such as cybersecurity, artificial intelligence and data analytics, FinTech and InsurTech, as well as MedTech and digital health.

This strategic evolution is already underway through the Company’s recently announced plan to acquire a majority stake in Scentech, an artificial intelligence diagnostics company developing non-invasive, breath-based disease-detection technologies. The proposed Scentech transaction, structured around clinical, regulatory, and operational milestones, represents the Company’s first anticipated acquisition under EZRA International Group and reflects the Company’s intention to pursue high-impact, technology-driven opportunities with significant long-term upside potential.

Ezra Beyman, Chairman and Chief Executive Officer of Reliance Global Group, commented, “With our transition of our ticker symbol to ‘EZRA’ we are positioning the Company for its next phase of growth. With the launch of EZRA International Group and our entry into the Scentech transaction, we are executing on a strategy designed to identify and scale breakthrough technologies that we believe can create meaningful, long-term value, complementing the stable, recurring cash flow of our current insurance holdings.”

No action is required by the Company’s shareholders in connection with the ticker symbol change. Existing share certificates will continue to be valid, and the Company’s common stock will trade seamlessly under the new symbol beginning January 26, 2026.

About Reliance Global Group, Inc.

Reliance Global Group, Inc. (NASDAQ: RELI) is an InsurTech pioneer, leveraging artificial intelligence (AI), and cloud-based technologies, to transform and improve efficiencies in the insurance agency/brokerage industry. The Company’s business-to-business InsurTech platform, RELI Exchange, provides independent insurance agencies an entire suite of business development tools, enabling them to effectively compete with large-scale national insurance agencies, whilst reducing back-office cost and burden. The Company’s business-to-consumer platform, 5minuteinsure.com, utilizes AI and data mining, to provide competitive online insurance quotes within minutes to everyday consumers seeking to purchase auto, home, and life insurance. In addition, the Company operates its own portfolio of select retail “brick and mortar” insurance agencies which are leaders and pioneers in their respective regions throughout the United States, offering a wide variety of insurance products. Further information about the Company can be found at https://www.relianceglobalgroup.com.

Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. You can identify these statements by terminology such as “may,” “should,” “could,” “would,” “will,” “expect,” “anticipate,” “intend,” “plan,” “believe,” “estimate,” “continue,” “potential,” and similar expressions. Forward-looking statements in this press release include, without limitation, statements regarding the intended strategic rationale for the Company’s ticker symbol change; the formation, objectives and anticipated activities of EZRA International Group; the Company’s acquisition strategy and ability to identify, structure and complete acquisitions of technology-enabled businesses; the proposed acquisition of a majority interest in Scentech and the anticipated timing, structure and potential benefits thereof; the scalability and long-term value potential of acquired or targeted technologies; and the Company’s broader business, strategic and financial outlook.

These forward-looking statements are based on current expectations and assumptions that involve risks and uncertainties, including, among others, that the Company will be able to successfully execute its acquisition-driven growth strategy through EZRA International Group; that the proposed Scentech transaction will be completed on anticipated terms or at all; that anticipated clinical, regulatory, operational or commercial milestones will be achieved; that acquired or targeted businesses will perform as expected; that market, economic, interest rate and regulatory conditions will remain sufficiently favorable; and that the Company will be able to continue to access capital on acceptable terms and execute its broader business and capital markets strategy. There can be no assurance that these assumptions will prove accurate.

Actual results could differ materially from those anticipated due to a variety of risks and uncertainties, including, without limitation, the risk that the ticker symbol change does not achieve its intended strategic or market perception objectives; the risk that the Company is unable to consummate the proposed Scentech transaction or future acquisitions; unanticipated costs, liabilities or integration challenges associated with acquisitions; risks inherent in investing in early-stage or emerging technology companies; regulatory, clinical or commercialization risks applicable to medical, artificial intelligence or data-driven technologies; the Company’s ability to obtain additional financing on acceptable terms; competitive pressures; and general business, economic, market, interest rate and geopolitical conditions; as well as other risks described under “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024, as amended, the Company’s Quarterly Reports on Form 10-Q, and in other filings with the Securities and Exchange Commission.

You are encouraged to carefully review the Company’s Annual Report on Form 10-K for the year ended December 31, 2024, as amended, as well as its other filings with the Securities and Exchange Commission, for a more complete discussion of these and other risks and uncertainties. Except as required by law, Reliance Global Group, Inc. undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.

Contact:

Crescendo Communications, LLC
Tel: +1 (212) 671-1020
Email: RELI@crescendo-ir.com

Transaction structured to achieve majority ownership through performance-based clinical and regulatory milestones

Marks first strategic acquisition for new division-Ezra International Group

Lakewood, NJ, Jan. 07, 2026 — Reliance Global Group, Inc. (NASDAQ: RELI) (“Reliance” or the “Company”) today announced that it has entered into a non-binding term sheet (“the term sheet”) to acquire a majority equity position of Scent Medical Technologies Ltd (“Scentech”). Scentech is a diagnostics company developing artificial intelligence technologies designed to identify disease-associated molecular signatures in human breath. Scentech’s product candidates are under development and have not yet been clinically validated or approved for commercial use. Any potential clinical or commercial outcomes remain subject to successful clinical validation and applicable regulatory clearances or approvals. The proposed transaction is expected to become the first asset within Ezra International Group, Reliance’s newly established division focused on strategic investments in technology-driven companies.

Scentech’s AI technology platforms include VOX™, a non-invasive breath-based diagnostic product candidate under development for early pancreatic cancer risk assessment, and VocTracer™, a laboratory-based system product candidate designed to detect biochemical signatures associated with healthcare-associated infections (“HAIs”) and antimicrobial resistance (“AMR”) potentially earlier than conventional culture readouts, subject to validation.

Scentech is developing a multi-indication detection platform product candidate based on the ability to identify disease-related biomarkers through molecular signatures in human breath. Subject to ongoing development and validation, these signatures are expected to be identified through non-invasive sampling or routine laboratory workflows using the Scentech artificial intelligence combined with specialized instrumentation.

Scentech’s initial development intends to address two areas of high unmet need:

• Pancreatic cancer is one of the deadliest major solid tumors. Scentech’s technology is designed to enable earlier detection.
• Healthcare-associated infections and antimicrobial resistance, which contribute to extended hospital stays, increased mortality, and excess healthcare costs.

Scentech’s platform is under development as a non-invasive approach for early detection and screening intended to complement existing diagnostic pathways and, subject to clinical validation and applicable regulatory clearance or approval, may help enable earlier triage prior to standard-of-care diagnostics such as imaging, molecular testing, or microbiology culture.

Clinical Foundation and Development Pathway

To date, Scentech has committed significant resources in laboratory infrastructure, automated sampling technologies, and hospital-based testing. Scentech’s product candidates remain under development. Any results to date are preliminary, do not establish clinical performance for any intended use, and the product candidates have not yet received regulatory clearance or approval in any jurisdiction.

Commercial and Market Considerations

Initial target markets for Scentech’s platform include pancreatic cancer risk assessment and HAI/AMR detection, which together are part of a potential $5-10 billion global market. The Company’s current commercial plan contemplates an ‘instrument-plus-consumables’ model, which-if successfully developed and commercialized-is expected to support recurring revenue from testing supplies and service-based software analytics. The Company intends to seek to commence commercialization as soon as practicable following successful clinical validation and, where applicable, receipt of required regulatory clearances or approvals, through a combination of licensing and direct distribution where it is viable.

Management Commentary

“We believe early detection has a meaningful impact on both patient outcomes and healthcare economics,” said Ezra Beyman, Chairman and Chief Executive Officer of Reliance Global Group. “Through the acquisition of a majority equity interest of Scentech, we believe we are expanding our reach into the broader health-tech ecosystem, if successfully developed, validated and approved for commercialization. We believe this acquisition aligns with our core mission of using artificial intelligence to disrupt traditional industries and create long-term value for our shareholders. The proposed transaction is expected to represent the first strategic acquisition by Ezra International Group, Reliance’s newly launched subsidiary focused on technology-enabled companies, including healthcare and data-driven platforms.”

Mr. Beyman added, “The structure we are contemplating is being carefully designed with the intention of securing majority control while managing development and execution risk through a milestone-based structure. We believe this approach positions Reliance to participate in the long-term value creation potential of a scalable detection platform.”

Reliance expects to obtain majority ownership of Scentech, subject to the achievement of defined clinical, regulatory, and operational milestones over a period of time. Completion of the transaction is subject to the execution of definitive agreements and satisfaction of customary closing conditions, including diligence.

Development and Regulatory Status

VOX and VocTracer are investigational product candidates under development and have not been clinically validated for any intended use. They are not cleared or approved for commercial sale in any jurisdiction, and any commercialization would be subject to successful clinical validation and applicable regulatory clearances or approvals, which may be time-consuming and uncertain.

About Scentech

Scentech is a diagnostics company developing breath-based molecular testing platforms intended to detect disease-associated biochemical signatures. Its initial product candidates, VOX and VocTracer, are in development to combine high-sensitivity chemical analysis, automated sampling, and machine-learning-driven analytics and, subject to clinical validation and applicable regulatory clearances or approvals, may support early disease detection and infection surveillance. The platform is intended to be expandable across multiple indications in oncology and infectious diseases. VOX and VocTracer are investigational product candidates and are not cleared or approved for commercial sale.

About Reliance Global Group, Inc.

Reliance Global Group, Inc. (NASDAQ: RELI) is an InsurTech pioneer, leveraging artificial intelligence (AI), and cloud-based technologies, to transform and improve efficiencies in the insurance agency/brokerage industry. The Company’s business-to-business InsurTech platform, RELI Exchange, provides independent insurance agencies an entire suite of business development tools, enabling them to effectively compete with large-scale national insurance agencies, whilst reducing back-office cost and burden. The Company’s business-to-consumer platform, 5minuteinsure.com, utilizes AI and data mining, to provide competitive online insurance quotes within minutes to everyday consumers seeking to purchase auto, home, and life insurance. In addition, the Company operates its own portfolio of select retail “brick and mortar” insurance agencies which are leaders and pioneers in their respective regions throughout the United States, offering a wide variety of insurance products. Further information about the Company can be found at https://www.relianceglobalgroup.com.

Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. You can identify these statements by terminology such as “may,” “should,” “could,” “would,” “will,” “expect,” “anticipate,” “intend,” “plan,” “believe,” “estimate,” “continue,” “potential,” and similar expressions. Forward-looking statements in this press release include, without limitation, statements regarding: the proposed transaction with Scentech, including the negotiation, execution and anticipated terms of definitive agreements; the anticipated timing, structure and terms of any such transaction; the Company’s ability to obtain majority ownership and the anticipated clinical, regulatory, operational or other milestones related thereto; the anticipated benefits of the proposed transaction; Scentech’s product development plans and the expected capabilities, performance, clinical validation, regulatory pathway and commercialization of VOX, VocTracer and related technologies; the size and growth of the markets referenced; and the Company’s broader business, strategic and financial outlook. Forward-looking statements are not guarantees of future performance and you should not place undue reliance on them. These statements speak only as of the date of this press release.

These forward-looking statements are based on current expectations and assumptions that involve risks and uncertainties. Market and industry data and projections are based on estimates, assumptions and third-party sources and may prove to be inaccurate. These risks and uncertainties include, among others: that discussions may not result in definitive agreements on the terms currently contemplated, or at all; that any definitive agreements, if executed, may include terms that differ materially from those currently contemplated; that conditions to closing (including due diligence, approvals and other customary conditions) may not be satisfied; that anticipated clinical, regulatory, operational or other milestones may not be achieved on the expected timeline or at all; that Scentech’s technologies may not perform as expected in broader or real-world settings; that required clinical validation and applicable regulatory clearances or approvals may not be obtained (or may be delayed, limited or subject to post-market requirements); that commercialization (including manufacturing scale-up, distribution, reimbursement, pricing and customer adoption) may not be successful; that integration, governance, intellectual property protection and competitive dynamics may present additional challenges; that the Company may require additional financing, which may not be available on acceptable terms or at all and may result in dilution; and that market, economic and regulatory conditions may change.

Actual results could differ materially from those anticipated due to a variety of risks and uncertainties, including, without limitation: the risk that the proposed transaction does not close or is delayed; the risk that definitive agreements differ materially from the parties’ current expectations; the risk that the Company does not obtain majority ownership or does not obtain it on the timeline or terms currently contemplated; the risk that Scentech’s product candidates do not achieve successful clinical validation, required regulatory clearances or approvals, or commercial adoption; the risk that anticipated market opportunities are smaller than expected; the risk of unanticipated costs, liabilities, disputes or disruptions associated with pursuing or completing the proposed transaction; and other risks described under “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024, as amended, its Quarterly Reports on Form 10-Q, and in other filings with the Securities and Exchange Commission.
You are encouraged to carefully review the Company’s filings with the Securities and Exchange Commission for a more complete discussion of these and other risks and uncertainties. Except as required by law, Reliance Global Group, Inc. undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.

Contact:

Crescendo Communications, LLC
Tel: +1 (212) 671-1020
Email: RELI@crescendo-ir.com

LAKEWOOD, NJ, Jan. 05, 2026 — Reliance Global Group, Inc. (Nasdaq: RELI) (the “Company”) today announced the unanimous Board approval for its formation of EZRA International Group, a new division focused on acquiring controlling stakes and accelerating growth of high-tech Israeli companies, with an initial focus on the Cybersecurity, AI & Data Analytics, FinTech & InsurTech, as well as MedTech & Digital Health sectors. Through this initiative, the Company intends to pursue a structured path toward value realization, which may include public listings, strategic spin-offs, or other monetization events designed to maximize shareholder value.

“We believe the current market capitalization of the Company does not fully reflect the intrinsic value and historic cash flow of our insurance operations,” said Ezra Beyman, Chief Executive Officer of Reliance Global Group. “The formation of EZRA International Group allows us to leverage both our public listing and anticipated cashflow to potentially provide our shareholders with exposure to the upside of innovative, high-growth technologies. The Board and management believe this strategy has the potential to unlock significant value for the Company’s shareholders. We look forward to providing further updates regarding EZRA International Group, including initial transactions, as developments occur.”

EZRA International Group will focus on acquiring significant ownership stakes, enabling the Company to support and influence strategy, governance, capital formation, and execution. This approach is intended to position the Company to drive long-term growth and value creation across its portfolio.

The Company believes that this strategy will benefit from leveraging ties and expertise in the Israeli innovation ecosystem. Recent moves by prominent venture capitalists hint at the depth of technical talent, entrepreneurial culture, and capital efficiency, aligning with EZRA International Group’s strategy of acquiring significant positions in businesses that can be scaled and supported into global capital markets access and entry.

About Reliance Global Group, Inc.

Reliance Global Group, Inc. (NASDAQ: RELI) is an InsurTech pioneer, leveraging artificial intelligence (AI), and cloud-based technologies, to transform and improve efficiencies in the insurance agency/brokerage industry. The Company’s business-to-business InsurTech platform, RELI Exchange, provides independent insurance agencies an entire suite of business development tools, enabling them to effectively compete with large-scale national insurance agencies, whilst reducing back-office cost and burden. The Company’s business-to-consumer platform, 5minuteinsure.com, utilizes AI and data mining, to provide competitive online insurance quotes within minutes to everyday consumers seeking to purchase auto, home, and life insurance. In addition, the Company operates its own portfolio of select retail “brick and mortar” insurance agencies which are leaders and pioneers in their respective regions throughout the United States, offering a wide variety of insurance products. Further information about the Company can be found at https://www.relianceglobalgroup.com.

Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. You can identify these statements by terminology such as “may,” “should,” “could,” “would,” “will,” “expect,” “anticipate,” “intend,” “plan,” “believe,” “estimate,” “continue,” “potential,” and similar expressions. Forward-looking statements in this press release include, without limitation, statements regarding: our strategic initiatives, including our efforts to streamline our portfolio, monetize non-core assets and focus resources on areas with the strongest strategic and financial potential; the anticipated benefits of the sale of Employee Benefits Solutions, LLC and U.S. Benefits Alliance, LLC (together, “EBS”), including the impact on our business focus, financial position and capital structure; our expectations regarding the use of proceeds from the EBS transaction, including our plan to use a portion of the net proceeds to further reduce debt and the balance toward business development initiatives that support long-term growth; our beliefs regarding the growth prospects and scalability of RELI Exchange and 5minuteinsure.com and the potential impact of incremental investment in those platforms on our competitive positioning and financial performance; and our broader business, strategic and financial outlook.

These forward-looking statements are based on current expectations and assumptions that involve risks and uncertainties, including, among others, that we will be able to successfully execute our strategy to streamline our portfolio and focus on core, technology-forward platforms; that we will be able to realize the anticipated strategic, operational and financial benefits of the EBS divestiture; that we will be able to effectively allocate and deploy the proceeds from the EBS sale, including to reduce debt and fund business development initiatives; that our investments in RELI Exchange, 5minuteinsure.com and other initiatives will generate the anticipated returns; that market, economic, interest rate and regulatory conditions will remain sufficiently favorable; and that we will be able to continue to access capital on acceptable terms and execute our broader business and capital markets strategy. There can be no assurance that these assumptions will prove accurate.

Actual results could differ materially from those anticipated due to a variety of risks and uncertainties, including, without limitation: our ability to realize the anticipated benefits of the EBS divestiture; the possibility of unanticipated costs, liabilities or disruptions associated with the transaction, including any impact on our remaining operations, employees, customers or business partners; our ability to successfully reduce debt and improve our leverage and overall financial flexibility; our ability to grow RELI Exchange and 5minuteinsure.com, attract and retain agents and customers, and achieve expected levels of adoption and profitability; our ability to effectively deploy capital into business development or other strategic initiatives; our ability to maintain adequate liquidity and access to capital (including any issuance under our at-the-market equity offering program, if utilized); competitive pressures, including within InsurTech and insurance agency/brokerage; and general business, economic, market, interest rate and geopolitical conditions; as well as other risks described under “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2024, as amended, our Quarterly Reports on Form 10-Q, and in other filings with the Securities and Exchange Commission.

You are encouraged to carefully review our Annual Report on Form 10-K for the year ended December 31, 2024, as amended, as well as our other filings with the Securities and Exchange Commission, for a more complete discussion of these and other risks and uncertainties. Except as required by law, Reliance Global Group, Inc. undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.

Contact:

Crescendo Communications, LLC
Tel: +1 (212) 671-1020
Email: RELI@crescendo-ir.com